Egeghy PP, Judson R, Gangwal S, Mosher S, Smith D, Vail J, et al. The exposure data landscape for manufactured chemicals. Sci total Environ. 2012;414:159–66.
Article CAS PubMed Google Scholar
Breyer S. Breaking the vicious circle: toward effective risk regulation. Cambridge (MA): Harvard University Press; 2009.
Judson R, Richard A, Dix DJ, Houck K, Martin M, Kavlock R, et al. The toxicity data landscape for environmental chemicals. Environ Health Perspect. 2009;117:685.
Article CAS PubMed Google Scholar
Kavlock RJ, Bahadori T, Barton-Maclaren TS, Gwinn MR, Rasenberg M, Thomas RS. Accelerating the pace of chemical risk assessment. Chem Res Toxicol. 2018;31:287–90.
Article CAS PubMed PubMed Central Google Scholar
Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. The toxcast program for prioritizing toxicity testing of environmental chemicals. Toxicological Sci. 2006;95:5–12.
Collins FS, Gray GM, Bucher JR. Transforming environmental health protection. Science. 2008;319:906.
Article CAS PubMed PubMed Central Google Scholar
Breen M, Ring CL, Kreutz A, Goldsmith MR, Wambaugh JF. High-throughput PBTK models for in vitro to in vivo extrapolation. Expert Opin Drug Metab Toxicol. 2021;17:903–21.
Article CAS PubMed Google Scholar
Coecke S, Pelkonen O, Leite SB, Bernauer U, Bessems JG, Bois FY, et al. Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches. Toxicol Vitr. 2013;27:1570–7.
Bessems JG, Loizou G, Krishnan K, Clewell HJ III, Bernasconi C, Bois F, et al. PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA–EURL ECVAM ADME workshop. Regulatory Toxicol Pharmacol. 2014;68:119–39.
Wambaugh JF, Bare JC, Carignan CC, Dionisio KL, Dodson RE, Jolliet O, et al. New approach methodologies for exposure science. Curr Opin Toxicol. 2019;15:76–92.
Pearce RG, Setzer RW, Strope CL, Sipes NS, Wambaugh JF. Httk: R package for high-throughput toxicokinetics. J Stat Softw. 2017;79:1–26.
Article PubMed PubMed Central Google Scholar
Health Canada. Science approach document—bioactivity exposure ratio: application in priority setting and risk assessment. 2021.
Paul Friedman K, Gagne M, Loo LH, Karamertzanis P, Netzeva T, Sobanski T, et al. Utility of in vitro bioactivity as a lower bound estimate of in vivo adverse effect levels and in risk-based prioritization. Toxicol Sci. 2020;173:202–25.
U.S. Congress, Frank R. Lautenberg chemical safety for the 21st century act. Public Law 114–182 (114th Congress). Washington, DC: U.S. Congress; 2016.
Ring CL, Pearce RG, Setzer RW, Wetmore BA, Wambaugh JF. Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability. Environ Int. 2017;106:105–18.
Article CAS PubMed PubMed Central Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Article PubMed PubMed Central Google Scholar
Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 2019;322:113–4.
UW Medicine to exclude race from calculation of eGFR (measure of kidney function) [press release]. Seattle (WA): University of Washington Department of Medicine; 2020.
Delgado C, Baweja M, Burrows NR, Crews DC, Eneanya ND, Gadegbeku CA, et al. Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN task force. Am J Kidney Dis. 2021;78:103–15.
Article PubMed PubMed Central Google Scholar
Delgado C, Baweja M, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79:268–88.e1.
Kaufman JD, Hajat A. Confronting environmental racism. Environ Health Perspect. 2021;129:51001.
U.S. Environmental Protection Agency. Environmental Justice. 2022. https://www.epa.gov/environmentaljustice.
Wambaugh JF, Hughes MF, Ring CL, MacMillan DK, Ford J, Fennell TR, et al. Evaluating in vitro-in vivo extrapolation of toxicokinetics. Toxicological Sci. 2018;163:152–69.
Wambaugh JF, Wetmore BA, Ring CL, Nicolas CI, Pearce RG, Honda GS, et al. Assessing toxicokinetic uncertainty and variability in risk prioritization. Toxicol Sci. 2019;172:235–51.
Article CAS PubMed Google Scholar
Tonnelier A, Coecke S, Zaldívar J-M. Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model. Arch Toxicol. 2012;86:393–403.
Article CAS PubMed Google Scholar
Wetmore BA, Wambaugh JF, Allen B, Ferguson SS, Sochaski MA, Setzer RW, et al. Incorporating high-throughput exposure predictions with dosimetry-adjusted in vitro bioactivity to inform chemical toxicity testing. Toxicol Sci. 2015;148:121–36.
Article CAS PubMed PubMed Central Google Scholar
Johnson TN, Rostami-Hodjegan A, Tucker GT. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin Pharmacokinet. 2006;45:931–56.
Article CAS PubMed Google Scholar
Bernstein AS, Kapraun DF, Schlosser PM. A model template approach for rapid evaluation and application of physiologically based pharmacokinetic models for use in human health risk assessments: a case study on per- and polyfluoroalkyl substances. Toxicol Sci. 2021;182:215–28.
Article CAS PubMed Google Scholar
Kim SJ, Choi EJ, Choi GW, Lee YB, Cho HY. Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model. Arch Toxicol. 2019;93:311–30.
Article CAS PubMed Google Scholar
Kriz W, Bankir L. A standard nomenclature for structures of the kidney. The Renal Commission of the International Union of Physiological Sciences (IUPS). Kidney Int. 1988;33:1–7.
Article CAS PubMed Google Scholar
Strope CL, Mansouri K, Clewell HJ, Rabinowitz JR, Stevens C, Wambaugh JF. High-throughput in-silico prediction of ionization equilibria for pharmacokinetic modeling. Sci Total Environ. 2018;615:150–60.
Article CAS PubMed Google Scholar
Mansouri K, Cariello NF, Korotcov A, Tkachenko V, Grulke CM, Sprankle CS, et al. Open-source QSAR models for pKa prediction using multiple machine learning approaches. J Cheminformatics. 2019;11:1–20.
Mansouri K, Grulke CM, Judson RS, Williams AJ. OPERA models for predicting physicochemical properties and environmental fate endpoints. J Cheminformatics. 2018;10:10.
Williams WW, Hogan JW, Ingelfinger JR. Time to eliminate health care disparities in the estimation of kidney function. N Engl J Med. 2021;385:1804–6.
Duggal V, Thomas IC, Montez-Rath ME, Chertow GM, Kurella, Tamura M. National estimates of CKD prevalence and potential impact of estimating glomerular filtration rate without race. J Am Soc Nephrol. 2021;32:1454–63.
Article PubMed PubMed Central Google Scholar
Young BA. Removal of race from estimation of kidney function. Nat Rev Nephrol. 2022;18:201–2.
Hsu CY, Yang W, Parikh RV, Anderson AH, Chen TK, Cohen DL, et al. Race, genetic ancestry, and estimating kidney function in CKD. N. Engl J Med. 2021;385:1750–60.
Article CAS PubMed PubMed Central Google Scholar
Levey AS, Titan SM, Powe NR, Coresh J, Inker LA. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol. 2020;15:1203–12.
留言 (0)